AlzBiomarker
Alzheimer's Disease vs Control: Aβ42 (Plasma and Serum)
Meta-analysis Results: Plasma levels of Aβ42 were not significantly different between people with Alzheimer’s disease and controls (effect size = 1.031, p = 0.38718), with considerable variability between studies.

